Telaprevir: Added benefit in certain patients with hepatitis C

The new drug telaprevir offers advantages in various groups of patients with chronic hepatitis C infection of genotype 1. The available studies provide proof, indications or "hints" of an added benefit. However, not only the probability but also the extent of added benefit varies, according to a new assessment.

Read the whole article on Science Daily

More from Science Daily